Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients.
Tasaki Y, Ito N, Mimura Y, Sugiyama Y, Ogawa R, Shimura T, Nakamura M, Kawakita D, Hamamoto S, Uemura T, Yokota K, Iida M, Odagiri K, Kimura Y, Hotta Y, Komatsu H, Okuda K, Niimi A, Yasui T, Iwasaki S, Morita A, Kataoka H, Takiguchi S, Furukawa-Hibi Y. Tasaki Y, et al. Among authors: odagiri k. Asia Pac J Clin Oncol. 2024 Apr 29. doi: 10.1111/ajco.14073. Online ahead of print. Asia Pac J Clin Oncol. 2024. PMID: 38682421
GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma.
Sugiyama Y, Naiki T, Tasaki Y, Mimura Y, Etani T, Noda Y, Nozaki S, Shimizu N, Banno R, Nagai T, Isobe T, Ando R, Moritoki Y, Kataoka T, Odagiri K, Aoki M, Gonda M, Yasui T, Hibi Y. Sugiyama Y, et al. Among authors: odagiri k. Oncology. 2023;101(4):224-233. doi: 10.1159/000529203. Epub 2023 Jan 23. Oncology. 2023. PMID: 36689919
Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma.
Tomiyama N, Tasaki Y, Hamamoto S, Sugiyama Y, Naiki T, Etani T, Taguchi K, Matsuyama N, Sue Y, Mimura Y, Odagiri K, Noda Y, Aoki M, Moritoki Y, Nozaki S, Kurokawa S, Okada A, Kawai N, Furukawa-Hibi Y, Yasui T. Tomiyama N, et al. Among authors: odagiri k. Int J Urol. 2023 Sep;30(9):754-761. doi: 10.1111/iju.15198. Epub 2023 May 7. Int J Urol. 2023. PMID: 37150513
Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.
Tasaki Y, Sugiyama Y, Hamamoto S, Naiki T, Uemura T, Yokota K, Kawakita D, Nakamura M, Ogawa R, Shimura T, Mimura Y, Hotta Y, Odagiri K, Ito N, Iida M, Kimura Y, Komatsu H, Kataoka H, Takiguchi S, Morita A, Iwasaki S, Okuda K, Niimi A, Yasui T, Furukawa-Hibi Y. Tasaki Y, et al. Among authors: odagiri k. Cancer Med. 2023 Dec;12(24):21666-21679. doi: 10.1002/cam4.6724. Epub 2023 Nov 21. Cancer Med. 2023. PMID: 37986680 Free PMC article.
Delivery catheter system carries more physiological right ventricular septal pacing than stylet system.
Hasebe H, Naruse Y, Sano M, Kurebayashi N, Morikawa S, Tsurumi N, Shiozawa T, Takano S, Ogano M, Kimura K, Miyajima K, Sugiura R, Henmi R, Muto M, Hosoya N, Mizukami A, Iguchi K, Atsumi A, Odagiri K, Kiyama Y, Maekawa Y; Mt. FUJI trial investigators. Hasebe H, et al. Among authors: odagiri k. J Cardiovasc Electrophysiol. 2024 Apr;35(4):802-810. doi: 10.1111/jce.16226. Epub 2024 Feb 26. J Cardiovasc Electrophysiol. 2024. PMID: 38409896 Clinical Trial.
Denosumab-induced hypocalcemia in patients with solid tumors and renal dysfunction: a multicenter, retrospective, observational study.
Nakamura K, Kaya M, Yanagisawa Y, Yamamoto K, Takayashiki N, Ukita H, Nagura M, Sugiue K, Kitajima M, Hirano K, Ishida H, Onoda C, Kobayashi Y, Nakatani E, Odagiri K, Suzuki T. Nakamura K, et al. Among authors: odagiri k. BMC Cancer. 2024 Feb 15;24(1):218. doi: 10.1186/s12885-024-11942-2. BMC Cancer. 2024. PMID: 38360579 Free PMC article.
151 results